Acute Effects of 1-[Bis(4-fluorophenyl)methyl]-4-(2, 3, 4-trimethoxybenzyl) piperazine dihydrochloride, KB-2796, on the Cerebral Blood Flow in Unanesthetized Cats by 金澤, 稔郎 et al.
Title
無麻酔不動化ネコにおける1-[Bis(4-fluorophenyl)methyl]-4-
(2, 3, 4-trimethoxybenzyl) piperazine dihydrochloride (KB-
2796)の脳血流量に対する作用
Author(s)金澤, 稔郎; 中洲, 庸子; 松田, 昌之; 半田, 譲二




Type Departmental Bulletin Paper
Textversionpublisher
Kyoto University







Acute E旺ectsof 1・〔Bis(4-fluorophenyl) methyl]-4・（2,3,4・
trimethoxybenzyl) piperazine dihydrochloride, KB・
2796, on the Cerebral Blood Flow in 
U nanesthetized Cats 
TosHrno KANAZAWA, YoKo NAKAsu, MASAYUKI MATSUDA, 
and Jvo;r RANDA 
Department of Neurosurgery, Shiga University of Medical Science 
KB-2796, a new synthetic Ca++ entηy blocker, has been known to increase the vertebral 
artery flow, and cerebral cortical blood flow, in anesthetized dogs, and cats, respectively. In 
this experiment, effects of an intravenous administration of KB-2796 on the regional blood flow 
in the ectosylvian gyrus, occipital gyrus, thalamus and the medulla, of unanesthetized, immobi-
lized cats were studied using hydrogen clearance method. 
Systemic blood presure showed a mild decrease, but pC02, p02, and pH of the arterial 
blood remained unchanged during the experiments. An intravenous administration of 0.1 and 
0.3 mg/kg of KB-2796 showed a dose dependent increase in the cerbral blood flow in al 4 regions 
measured唱theincrease having been most marked in the medulla. Effects of 1.0 mg/kg did not 
differ significantly from those of 0.3 mg/kg. The cerebral blood flow and blood pressure restored 
to the steady state values within 30 minutes. 
It has been reported that several drugs known to increase the cerebral blood flow in 
anesthetized experimental animals fail to show any such effects in unanesthetized conditions. 
It is stressed that KB-2796 does increase the cerebral blood flow significantly in cats in unanesthe-
tized, immobilized condition. 
Key words: Calcium entry blocker, Cerebral vasodilation, Hydrogen clearance technique, KB-2796, Regional 
cerebral blood flow. 
索引語・脳血管拡張薬，カルシウム桔抗薬，脳局所血流量，水素クリアランス法， KB-2796.
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Table 1. Pretreatment values of physiological parameters, cerebral blood flow and 
cerebral vascular resistance. 
co. KB-2796 (i.v.) 
Parameters inhalation O~l＝~g～／~g 0~3=7g～／~g n=8 
Mean arterial pressure (mmHg) 143.3土4.4 139.9士5.2 136. 5±4. 5 137.1±8.3 
Heart rate (beats/min) 218.8土6.3 208.1±7. 2 211. 4土7.4 210.4土8.9
Cerebral blood flow (ml/100 g/min) 
Ectosylvian gyms 50.1±7. 0 44.6土6.8 46.1±7.4 45.1土7.8
Occipital gyms 42.0土3.6 39.1土4.5 37.4土5.7 39.0±5.3 
Thalamus 44.5土4.3 41.0土3.2 37.8士2.9 39.0土3.3
Medulla 33.9土2.2 32.5土3.1 36. 5±5. 2 39.6土6.8
Cerebral vascular resistance (mmHg/ml/100 g/min) 
Ectosylvian gyms 3.4土o.5 3.7土o.6 3-6士o.6 3.8土0.7
Occipital gyms 3. 6±0. 3 3. 8±0. 5 4.1土o.5 3.8土o.5
Thalamus 3.5土o.3 3.6土0.3 3. 8土0.3 4.0土o.5
Medulla 4.4土o.3 4.6土0.4 4.2土0.5 4.0土o.6
Each value represents the mean土S.E.M. n: Number of experiments. 
KB-2796(0.1, 0. 3, 1 mg/kg）の静脈内投与により平 用量相関性IC増加したが 1mg/kgの用量ではMを除
均動脈圧は用量依存性に下降した．心拍数は0.1およ いて 0.3mg/kg投与時以上の効果は得られなかった
び 0.3mg/kgにおいては用量に依存して増加したが KB-2796 0. 3 mg/kgの投与による脳各部位の血流量
1 mg/kgの用量では減少した（table3, fig. 3）.脳局所 増加の程度は M>ES>T>OCCの順に大きしそれ
血流量は0.1および0.3mg/kg においては各部位とも ぞれ増加率で26.5±7. 5, 20. 2土4.4,14.4士4.3およ
Table 2. Effects of C02 inhalation on blood gas, cerebral blood flow and cerebral vascular 
resistance in unanesthetized, immobilized cat. 
Parameters Control co. 30 min inhalation later 
Blood gas 
PaC02 (mmHg) 29.8士1.1 48.4士 2.1紳 31.1 ±o. 9 
Pa02 (mmHg) 101.4士1.9 100. 5 ± 1.5 103.4 ±1.5 
pH 7.39士0.01 7-23士 0.01** 7.39±0.01 
Mean arterial pressure (mmHg) 144.3土4.4 148. 0 ± 4.4* 144.4土4.7
Heart rate (beats/min) 218.8土6.3 195. 5 ± 7.2** 210. 0 ±8.8 
Cerebral blood自ow(ml/100 g/min) 
Ectosylvian gyms 50.1 ±7.0 80.0土11.1** 44-6土6.8*
Occipital gyms 42.0土3.6 80.3土 9.8** 39.1土4.5* 
Thalamus 44. 5 ±4. 3 106.3土 7.7** 41.0土3.2
Medulla 33. 9 ±2. 2 79.3土 6.9** 34.0土2.8
Cerebral vascular resistance (mmHg/ml/100 g/min) 
Ectosylvian gyms 3.4土0.5 2.2士 0.4** 3.8土o.6柿
Occipital gyms 3. 6 ±0. 3 2.1 ± o. 3** 4.0土o.5
Thalamus 3.5土o.3 1.5土 0.1** 3.7 ±0.3 
Medulla 4.4土0.3 2.0土 0.2＊キ 4.7 ±0.4 
Each value represents the mean土S.E.M.of 8 experiments. キ p<0.05，料 Pく0.01(paired-t test). 
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Fig. l. Effects of C02 inhalation on mean arterial 
pressure (MAP), heart rate (HR) and cere-
bral blood flow in unanesthetized, immobi-
Ii zed国匂（mean士s.E.M. of 8 experiments). 
ES: ectosylvian gyrus, OCC: occipital gyrus, 
T: thalamus, M: Medulla. 
*:pく0.05,**: pく0.01(paired-t test). 
び10.0土2-6%であった（fig.3）.脳各部位における血
管抵抗はaceではo.3および1mg/kgで，その｛也の


























Fi~. 2. Effects of C02 inhalation on cerebral vascu・
lar resistance (mean土S.E.M.of 8 experi-
ments). ES: ectosylvian gyrus, OCC: occi-
pita! gyrus, T: thalamus, M: medulla. 
ネ： Pく0.05，料： Pく0.01(paired-t test). 
niqueを用いて報告している．また，閉じくカルシウ






















書Effects of KB-2796 on blood gas, cereural blood flow and cerebral vascular resistance in unanesthetized, immobilized cat. Table 3. 
1 mg/kg 
5min 
0.3 mg/kg 0.1 mg/kg 
Blood gas 
PaC02 (mmHg) 31. 1土o.9 30. 0土o.6 - 30. 3士1.0 29 7土 Q.7 - 28.9土o.5 28. 6 ± o.7 
Pa02 (mmHg) 102. 6士1.8 98. 7土4.8 "' 100. 2土3.0 79.3士 2.9 - 104. 2土2.8 100.6土 3.9
pH 7,39士o.01 7, 40±4. 5 - 7. 40土o.01 7.41土 0.01 ー 7.40士o.02 7. 39± 0. 01 
Mean arterial pressure {mmHg) 139. 9 ±5. 2 133. 3土4.5 138. 9士4.8136. 5土4.7 120.1 ± 4.7 133. 6土4.1 137.1土8.3 118.1土lQ.7車＊ 141. 7土 6.8
Heart rate (beats/min) 208. 1土7.2 214. 6土7.2* 211. 3士7.2 211.4土7.4 221.6土 7.3**210. 3士6.5 210. 4土8.9 201. 1士 9.2 198. 3土 7.7*

























57. 4 ±12. 2 
42.5土 7.7
40.0土 4.6
54. 6 ±10. 6* 
control 
56.5土10.2噂 51.4土8.6* 45.1土7.8
40・6土 5.5キ＊ 37.6土5.2 39.0土5.3
43.0土 3.6**37. 4±3. 5 36. 0土3.3
46.1士 6.6* 37. 9±4. 0 39. 6土6.8
30min 5min control 
48.6士7.7 46.1士7.4 46.1土7.4
42.1土6.6 38.0±5.7 37.4土5.7
44.5土3.9* 37. 6土3.0 37. 8士2.9
37.8土3.9ホ＊ 36. 8土5.1 36. 5土5.2


















2.7 ± o.5** 
3.2士 0.3柿
2.9士 0.3糾
























































Fig. 3. Effects of intravenous administration of KB-2796 on mean arterial pressure 
(MAP), heart rate (HR) and cerebral blood flow (mean士S.E.M.of 6 to 8四 peri-
ments). EC: ectosylvian gyrus, OCC: occipital gyrus, T: thalamus, M: medulla. 






















Fig. 4. Effects of intravenous administration of KB-2796 on cerebral vascular resistance 
(mean土S.E.M.of 6 to 8 experiments). ES: ectosylvian gyrus, OCC: occipital 
gyrus, T: thalamus, 11: medulla. O: 0.1 mg/kg，・： 0.3mg/kg，ム： 1mg/kg. 
ホ： p<0.05，紳： pく0.01(paired-t test). 





























1. KB-2796は 0.1, 0. 3 mg/kgの静脈内投与によ
り無麻酔・不動化ネコの脳血流量を用量相関的iζ増加
させた.1. 0 mg/kgの効果は 0.3 mg/kgのそれと有
意の差はなかった．
z. hydrogen clearance technique による測定で， KB
2796のネコ脳血流量増加作用には部位差がみられ，
作用は延鎚でもっともつよかった．
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